期刊文献+

不稳定心绞痛患者术前给予不同剂量阿托伐他汀对PCI术后心肌损伤的影响 被引量:5

Effects of myocardial injury of different doses of atorvastatin in unstable angina pectoris patients after PCI
原文传递
导出
摘要 目的 :探讨经皮冠状动脉介入(PCI)术前24h内给予负荷剂量(80mg)阿托伐他汀对不稳定心绞痛患者PCI术后心肌损伤的影响。方法 :将200例需经PCI治疗不稳定心绞痛患者根据随机数字表法分为观察组和对照组,观察组术前应用80mg阿托伐他汀,对照组术前给予20mg阿托伐他汀。比较两组肌钙蛋白、B型脑钠肽前体(NT-pro BNP)、高敏C-反应蛋白(Hs-CRP)、肌酸激酶同工酶(CK-MB)水平变化情况以及患者术后1月内随访不良心血管事件发生率。结果 :(1)两组患者手术后心肌肌钙蛋白、NT-pro BNP、Hs-CRP、CK-MB水平明显高于手术前,差异有统计学意义,观察组上述指标明显低于对照组,差异有统计学意义;(2)观察组心源性再住院、心绞痛复发发生率及心血管事件总发生率均明显低于对照组,差异均有统计学意义。结论 :PCI术前应用负荷剂量阿托品能够有效的降低PCI术后心肌损伤,并能够降低患者心血管事件发生率。 Objective To study the percutaneous coronary intervention (PCI) in the preoperative 24h loading dose (80mg) of atorvastatin on patients with unstable angina pectoris myocardial injury after PCI operation. Method 200 patients required by PCI in the treatment of unstable angina pectoris patients were divided into observation group and control group according to randomly number table, the observation group were treated with 80mg atorvastatin, The control group were given 20mg of atorvastatin. troponin, B pro brain natriuretic peptide (NT-proBNP), Gao Min C- reactive protein (Hs-CRP), creatine kinase isoenzyme (CK-MB) changes of two groups were compared. The incidence of postoperative adverse cardiovascular events was followed 1 mounth after PCI. Results the operation of cardiac troponin, NT-proBNP, Hs-CRP, CK-MB levels of the two groups were significantly higher than that before operation, the difference was statistically significant,The above indexes of observa-tion group was significantly lower than that of control group, The difference was statistically significant; the incidence of cardiac readmission, Recurrence of angina and cardiovascular events of the observation group were significantly lower than the control group, The differences were statistically significant. Conclusion loading dose of atropine can effectively reduce myocardial damage after PCI, and can reduce the incidence of cardiovascular events.
出处 《湖南师范大学学报(医学版)》 2016年第1期89-92,共4页 Journal of Hunan Normal University(Medical Sciences)
关键词 经皮冠状动脉介入 阿托伐他汀 心绞痛 心肌 心肌酶 percutaneous coronary intervention Ato Vatatin angina pectoris myocardium myocardial enzyme
  • 相关文献

参考文献11

二级参考文献78

  • 1Auer J, Leitner A, Berent R, Lamm G, et al. Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation [J]. Atherosclerosis, 2010, 210(2): 503-509.
  • 2Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents , importance of delayed healing [ J ]. Atertio Thromb Vasc Biol, 2007,27(7): 1500-510.
  • 3Li W , Wang H, Kuang CY, et al. An essential role for the Id1/ PI3K1 Ak1NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro [ J]. Mol Cell Biochern, 2012, 363(1-2): 135-145.
  • 4Kang WC, Ahn TH, Moon CI, et al. Impact of arterial remodeling on high sensitive C-reactive protein after a DES implantation [ J]. Int J Cardiol, 2010, 145 (2) : 325-326.
  • 5Garg R, Tellez A, Alviar C, et al. The effect of percutaneous coro- nary intervention on inflammatory response and endothelial progenitor cell recruitment [ J]. Catheter Cardiovasc Interv, 2008, 72 ( 2) : 205-209.
  • 6Nakao A, Murase N, Ho C, et al. Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury [ J]. Circulation, 2005, 112 ( 4) : 587 -591.
  • 7Ostrowski SR, Johansson PI. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and earlyttraumatic coagulopathy[ J]. J Trauma Acute Care Surg, 2012, 73( 1): 60-66.
  • 8Dangas G, Fuster V. The role of platelet glycoprotein lIb/IlIa antagonists in percutaneous coronary revascularization procedures [ J ] . RevPortCardiol, 1999, 18( Suppl L) , 149-153.
  • 9Roller RE, Janisch S, Carroll V, et al. Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty [ J ]. Thromb Res, 1999, 94( 4) : 241-247.
  • 10Roffman OS. Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention[J]. Am J Health Syst Pharm, 2010, 67(15 Suppl 7) : SI8-24.

共引文献181

同被引文献43

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部